Abstract
An C-flumazenil positron emission tomography (PET) study in a patient with pallido-pyramidal disease revealed a marked decrease in benzodiazepine-receptor density in the precentral gyrus cortex and the mesial frontal cortex. We suggest that, in addition to dysfunction of basal ganglia-dependent systems, degeneration of the supplementary motor area could also be involved in the patient's bradykinesia.
Copyright 2001 Movement Disorder Society.
MeSH terms
-
Adult
-
Basal Ganglia Diseases / diagnostic imaging*
-
Basal Ganglia Diseases / genetics
-
Brain Mapping
-
Consanguinity
-
Dominance, Cerebral / physiology
-
Flumazenil
-
Frontal Lobe / diagnostic imaging
-
Globus Pallidus / diagnostic imaging*
-
Humans
-
Image Processing, Computer-Assisted
-
Imaging, Three-Dimensional
-
Male
-
Motor Cortex / diagnostic imaging*
-
Neurodegenerative Diseases / diagnostic imaging*
-
Neurodegenerative Diseases / genetics
-
Pyramidal Tracts / diagnostic imaging*
-
Receptors, GABA-A / metabolism
-
Tomography, Emission-Computed*
Substances
-
Receptors, GABA-A
-
Flumazenil